{"product_id":"texas-heart-institute-cardiometabolic-syndrome-conference-2024","title":"Texas Heart Institute Cardiometabolic Syndrome Conference 2024","description":"\u003ch3 class=\"product_title entry-title\"\u003eTexas Heart Institute Cardiometabolic Syndrome Conference 2024\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 20 videos, size: 4.67 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eTarget Audience: cardiologists, internists, hepatologists, endocrinologists, rheumatologists, pulmonologists, neurologists, gastroenterologists, surgeons\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eInformation:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cbr\u003e\u003cbr\u003eCardiometabolic syndrome (CMS) is a complex medical condition associated with significant morbidity, mortality, and cost. It is increasingly appreciated that the condition is also linked to non-cardiac disease including fatty liver disease and cancer. The underlying pre-morbid conditions for CMS include hypertension, insulin resistance and type II diabetes, elevated serum lipids, and obesity.\u003cbr\u003e\u003cbr\u003eDespite a deep understanding of the roles these pre-morbid conditions have on cardiovascular disease, liver disease, and malignancy and increasingly effective treatment strategies, the most recent projections from the US census and NHANES predict dramatic growth in each of the risk factors and subsequent clinical disease. This suggests that we need to look beyond standard healthcare solutions to the social drivers of health, new community partnerships, and innovative research programs if we intend to alter the trajectory of CMS. The proposed program will convene key stakeholders across a variety of disciplines to re-imagine new approaches for CMS.\u003cbr\u003e\u003cbr\u003eThe Cardiometabolic Syndrome Conference is designed to provide attendees with the most contemporary knowledge about the syndrome, including the epidemiology, treatment strategies, and knowledge gaps. There will be a specific focus on high-level discussions that dissect the current shortcomings in the overall management of CMS at the individual and community level and begin to consider new and innovative treatment strategies. The target audience is intended to be multidisciplinary and includes cardiologists, internal\/general medicine practitioners, hepatologists, endocrinologists, rheumatologists, pulmonologists, neurologists, gastroenterologists, surgeons, residents and fellows, physician assistants, nurse practitioners, nurses, and other allied health professionals.\u003cbr\u003e\u003cbr\u003eTexas Heart Institute Cardiometabolic Syndrome Conference 2024\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eLearning Objectives\u003c\/strong\u003e\u003cbr\u003e\u003cbr\u003eAt the conclusion of each lecture in the series, the participant should be able to:\u003cbr\u003e• Define the current epidemiology of CMS and its clinical consequences.\u003cbr\u003e• Review a guideline-based approach to screening and treatment of CMS.\u003cbr\u003e• Assess the growing burden of CMS on children.\u003cbr\u003e• Discuss prescribing food as a treatment for CMS.\u003cbr\u003e• Consider how to meaningfully integrate the social drivers of health into clinical practice.\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\u003cbr\u003eTexas Heart Institute Cardiometabolic Syndrome Conference 2024\u003cbr\u003e\u003cbr\u003e\u003cstrong\u003e Topics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eAn Employer Perspective on Community Health Initiatives.mp4\u003cbr\u003eBehavior Change and Health Outcomes in the Age of AI.mp4\u003cbr\u003eCardiometabolic Syndrome in Children A Sign of Things To Come.mp4\u003cbr\u003eCardiometabolic Syndrome in Women.mp4\u003cbr\u003eChanging Dietary Habits at the Population Level.mp4\u003cbr\u003eDefining the Epidemiologic Scope of Cardiometabolic Syndrome.mp4\u003cbr\u003eFrom Streets to Heartbeats Urban Environment and Cardiometabolic Health.mp4\u003cbr\u003eImpact of Contemporary Therapies on CMS.mp4\u003cbr\u003eImplementation Science to Improve Patient Engagement and Leveraging Systems to Enhance Care.mp4\u003cbr\u003eLeveraging Community Resources to Support Mental Health in the Workplace.mp4\u003cbr\u003eLooking at Community Health Trends with Survey Data The Greater Houston Community Panel.mp4\u003cbr\u003eNational Priorities on Lifestyle and Cardiometabolic Health.mp4\u003cbr\u003eOpening Plenary Session Panel Discussion Q\u0026amp;A.mp4\u003cbr\u003eResearch and Community Health Priorities Panel Discussion Q\u0026amp;A.mp4\u003cbr\u003eTechnology \u0026amp; Digital Health Innovations Non-Medical Management Panel Discussion Q\u0026amp;A.mp4\u003cbr\u003eThe Role of Local and State Governments.mp4\u003cbr\u003eUsing Big Data to Understand and Treat Cardiometabolic Syndrome.mp4\u003cbr\u003eWe Have the Tools, It’s Time To Unite The Intersection of CMH \u0026amp; MASLD MASH.mp4\u003cbr\u003eWe Know What To Do. Why Isn’t It Working.mp4\u003cbr\u003eWhat the Guidelines Tell Us About Cardiometabolic Syndrome.mp4\u003c\/li\u003e\n\u003c\/ul\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954444636258,"sku":"MED-AMB03661","price":20.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Texas-Heart-Institute-Cardiometabolic-Syndrome-Conference-2024.jpg?v=1779376899","url":"https:\/\/meducourse.com\/products\/texas-heart-institute-cardiometabolic-syndrome-conference-2024","provider":"Meducourse","version":"1.0","type":"link"}